00986cam2 2200241 450 E60020005495520131015102332.020091016d2001 |||||ita|0103 baitaITNordLiguria, Piemonte, Valle d'Aosta, Lombardia, Veneto, Trentino-Alto Adige, Friuli-Venezia Giulia, Emilia-RomagnaMilanoTouring Club Italiano2001216 p.ill.c.geog.33 cm001SOB0091622000 Atlante stradale d'Italia (1 : 200 000). Rete autostradale con tutte le informazioni di servizio. Piante di attraversamento (1 : 80 000). Piante di città ITUNISOB20131015RICAUNISOBUNISOB910|Atl107900E600200054955M 102 Monografia moderna SBNMCons910|Atl000038-1CON107900AcquistoNvittoriniUNISOBUNISOB20091016090302.020131015103409.0rovitoNord264061UNISOB03104nam 2200769z- 450 991055760260332120210501(CKB)5400000000045377(oapen)https://directory.doabooks.org/handle/20.500.12854/69310(oapen)doab69310(EXLCZ)99540000000004537720202105d2020 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierHost-Directed Therapies for TuberculosisBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20201 online resource (120 p.)3-03943-501-9 3-03943-502-7 TB is considered as one of the oldest documented infectious diseases in the world and is believed to be the leading cause of mortality due to a single infectious agent. Mtb, the causative agent responsible for TB, continues to afflict millions of people worldwide. Furthermore, one-third of the entire world's population has latent TB. Consequently, there has been a worldwide effort to eradicate and limit the spread of Mtb through the use of antibiotics. However, management of TB is becoming more challenging with the emergence of drug-resistant and multi-drug resistant strains of Mtb. Furthermore, when administered, many of the anti-TB drugs commonly present severe complications and side effects. Novel approaches to enhance the host immune responses to completely eradicate Mtb infection are urgently needed. This Special Issue will therefore cover most recent advances in the area of host-directed therapies for TB.Biology, life sciencesbicsscResearch & information: generalbicsscantioxidantsantiplateletaspirinautophagyBCG vaccinationco-infectionsco-morbiditiescytokinesgene expressionglutathionegranulomashost-directed therapiesimmune exhaustionimmune responseimmune responsesimmunomodulationinflammationinvasive procedureiron supplementationlatent infectionlung cancerM. tbmisdiagnosisMycobacterium tuberculosispathologyPerls' stainpulmonaryrabbitredox imbalancerevisingsurvivalTaiwantuberculosistype 2 diabetesBiology, life sciencesResearch & information: generalVenketaraman Vishwanathedt1303388Venketaraman VishwanathothBOOK9910557602603321Host-Directed Therapies for Tuberculosis3026986UNINA